Pacemakers and defibrillators

Chapter 25 Pacemakers and defibrillators



Nicholas P. Gall



Chapter contents



Summary


Basic cardiac electrophysiology


Pacemakers


Vagal nerve stimulators


Defibrillators


Electromagnetic interference



Summary




• Temporary pacing can be achieved in a number of ways; none are ideal.


• The indications for permanent pacemakers and implantable defibrillators are expanding. These devices are becoming increasingly complex.


• Strong sources of electromagnetic interference, diathermy for instance, can interact with pacemakers and defibrillators.


• Consultation with a cardiac electrophysiologist or cardiac technician is essential to understand the detailed functioning of these devices and to plan the treatment of patients.



Basic cardiac electrophysiology


While pacemakers and defibrillators are not strictly anaesthetic equipment, they are frequently encountered both in the elective and the emergency situation. An understanding of their hardware and software is important, not least because of their interaction with the strong electromagnetic fields that may be encountered in anaesthetic practice.


To understand pacemaker and defibrillator functioning, an understanding of normal cardiac electrophysiology is necessary. The myocardium consists of an interconnected network of myocytes. At rest, the myocyte interior is maintained at a negative potential (−80 mV) in relation to the extracellular fluid. This is due to the relative impermeability of the plasma membrane, differential intra- and extracellular ion concentrations and active ion transporters. Either because of the spontaneous inward leak of positively charged ions, in the sinus node for example, or because of an external electrical stimulus, the potential difference across the membrane decreases. At a threshold potential (approximately −70 mV in ventricular myocytes) various ion channels become activated producing further ion influx. This leads to myocyte depolarization and the action potential (Fig. 25.1). Calcium influx leads to the release of additional intracellular calcium stores activating the contractile apparatus, a process described as excitation-contraction coupling.


image

Figure 25.1 An action potential of a ventricular myocyte is shown on the left with that of a sinoatrial myocyte on the right.


Further ion movements, particularly potassium efflux, restore the myocyte’s potential to its resting value. During the early part of the action potential the myocyte cannot be induced to depolarize again – the absolute refractory period. Later on, a stimulus of sufficient strength can induce further depolarization – the relative refractory period.


Myocytes in different areas of the heart have different ion channels and, therefore, different action potentials. Some cells spontaneously discharge due to a resting inward leak of positively charged ions, with some cells, for example in the sinus node, discharging at a faster rate than others; this is known as automaticity. Due to the inter-linked nature of myocytes, the cells with the fastest rate of depolarization set the heart rate.



Pacemakers



Introduction


The association between a slow pulse and syncope was recognized at least 300 years ago. With the development of the electrocardiogram at the turn of the twentieth century, the various forms of bradycardia were defined. At the same time experimental electrical stimulation of cardiac cells was first studied, followed soon after by the first descriptions of the use of cardiac electrical stimulation as a therapeutic modality. Dramatic improvements followed in battery, capacitor and electronic technology, driven particularly by the Second World War. On 8 October 1958 the first entirely implantable epicardial cardiac pacemaker was inserted. A transvenous device followed in 1962. Multiple technological advances have followed, leading to the complex and reliable pacemakers we have today.


Pacing essentially involves passing a small electric current into the myocardium, usually with a wire that is placed endocardially. The stimulus, if it is of sufficient strength and outside the absolute refractory period, can induce myocyte and, subsequently, chamber depolarization.



The NASPE/BPEG code


With the increasing complexity of pacemakers, a three letter code was designed in 1974 by the Inter-Society Commission for Heart Disease Resources to define a pacemaker’s characteristics. This was refined in 1981 and subsequently led to the 1987 North American Society of Pacing and Electrophysiology (NASPE)/British Pacing and Electrophysiology Group (BPEG) five letter generic code.


The first letter of this code denotes the chamber(s) that are paced, the second letter the chamber(s) that are sensed, the third letter the response to sensing and the fourth letter programmability and rate response. The fifth letter, rarely used, denotes anti-tachycardia functions. NASPE/BPEG defibrillator (1993) and lead (1996) codes have also been designed.


In general terms, five forms of pacing are likely to be encountered clinically, the first four being available for both temporary and permanent pacing:




1. VVI. A single lead is placed in the ventricle, for pacing (VVI) and sensing (VVI). If the ventricular rate is above the minimum set (the base rate), pacing is inhibited (VVI). Otherwise pacing occurs.


2. AAI. A single lead is placed in the atrium. It functions in a similar way to the VVI and is used for sick sinus syndrome where AV nodal conduction is normal.


3. DDD. Leads are present in the atrium and ventricle. Both chambers (hence dual) can be paced (DDD) and sensed (DDD). If activity in either chamber is sensed a pacing stimulus will be inhibited. If no ventricular activity follows atrial activity, ventricular pacing will be triggered (DDD representing the dual responses of inhibition or triggering).


4. VOO/AOO/DOO. These are the simplest pacing modes. No sensing occurs (_O_) and therefore there can be no response to sensing (__O); the chamber(s) is paced at a fixed rate. This mode is used temporarily where the sensing of external noise could lead to the inappropriate inhibition of pacing, e.g. diathermy. It is also known as asynchronous pacing.


5. VDD. Only one lead is used which paces the ventricle (VDD). An electrode further up the lead is positioned in the atrium allowing dual chamber sensing (VDD). This allows physiological pacing, i.e. ventricular activity follows atrial at a physiological PR interval as long as atrial pacing is unnecessary. This mode is uncommon and is used as an alternative to DDD pacing in order to reduce system complexity.


6. The presence of an (R) as the fourth letter denotes a pacemaker able to increase the paced heart rate in response to the patient’s activity (see below, Software).



Pacing terminology


A number of pacing terms require explanation:




• Threshold (Fig. 25.2) – the minimum stimulus needed to capture the heart. It is given as current (amperes) or voltage (volts) over a time period (pulse width, ms).


• Unipolar/bipolar – refers to the arrangement (Fig. 25.3) of the negatively charged cathode and the positively charged anode. In the bipolar circuit, the cathode and the anode are separated by a short distance at the pacing lead tip. The circuit is localized to the immediate myocardium. In the unipolar circuit, the cathode is at the pacing lead tip with the anode at a distance; in the permanent pacing system it is found in the pacing box. The unipolar pacing circuit is larger and, therefore, produces a larger pacing artefact on the ECG. While there is little difference between the pacing characteristics of these two conformations, bipolar sensing is less susceptible to external noise.


• Impedance – this represents the total resistance to current flow in the pacing circuit. This resistance occurs in the leads, at the lead–myocardial interface for endocardial leads and in the tissue between the cathode and the anode. Fractures in the leads increase impedance, while insulation breaks reduce it.


image

Figure 25.2 A printout from a VVI pacemaker is shown. A standard ECG lead is seen at the top. The pacemaker marker channel is seen beneath, VP indicating ventricular pacing. The bottom line shows the electrogram seen by the bipolar lead. Loss of capture is seen at 1.1V.


image

Figure 25.3 Bipolar (A) and unipolar (B) pace/sense circuits are shown. Representative ECGs are shown beneath; note the larger pacing artefact on the unipolar ECG due to the larger pacing circuit.



Temporary pacing


Temporary pacing is used in emergency situations of life-threatening bradycardia or where a bradyarrhythmia could occur temporarily.



Transvenous pacing


This is the usual method for temporary pacing. A thin, semi-flexible, shaped, bipolar pacing lead is normally used. The central circulation is accessed via the internal jugular, subclavian or femoral veins, the first of these being preferable as there is a lower risk of complication (e.g. pneumothorax with the subclavian route, infection and deep vein thrombosis with the femoral). Furthermore, with the internal jugular approach, the veins used for permanent pacing are not directly punctured. The lead is manipulated into position at the right ventricular apex under X-ray guidance. Some leads may have a central shapeable stylet to allow more accurate positioning. Others have a tip-mounted flotation balloon to allow non-radiographic positioning. Active fixation (screw tipped) leads are also available to prevent lead displacement. In most cases one ventricular lead is used. Atrial pacing and dual chamber pacing are also possible. For temporary transvenous pacing, due consideration must be given to the possible need for permanent pacemaker insertion and the impact thereon of infection and local complications at vascular access. It is hence advisable to avoid the subclavian route and to use ultrasound guidance for vascular puncture. Various guidelines are listed in the bibliography section at the end of this chapter.


The pacing lead is connected to an external box which allows various programming options:




1. Mode: usually VVI (’demand’) or VOO (‘asynchronous’ or ‘fixed rate’)


2. Output: either the output voltage or current is programmable, the pulse width being fixed. Maximum outputs are higher than with permanent systems as battery size is unrestricted and the threshold is more unstable


3. Sensitivity: the threshold above which electrical activity will be detected as cardiac. This is usually measured in millivolts, a higher value indicating lower sensitivity


4. Rate: usually 30–150 or even higher for the overdrive pacing of tachyarrhythmias.



Transoesophageal and transgastric pacing


An electrode (on a device similar to an oesophageal stethoscope or nasogastric tube),1 placed in the oesophagus, can capture the left atrium, while in the stomach ventricular pacing may be possible. Transoesophageal atrial pacing (TAP) is a simple and safe method for temporary treatment of bradyarrhythmias and is particularly applicable to use during anaesthesia.2 Because voltages of up to 20V or more may be required to achieve capture (Fig. 25.2), a signal amplifier is needed if using an ordinary external (transvenous) pacing box (signal generator). TAP, like transgastric pacing, is rarely used because of unfamiliarity with the technique and scarcity of equipment.



Transcutaneous pacing


In the peri-arrest situation it may be difficult to position a transvenous temporary wire. It is possible to capture the ventricle by passing a large enough current through the chest using specially designed electrodes (Fig. 25.4). These electrodes may also be used for monitoring and defibrillation.


image

Figure 25.4 The suggested positioning for transcutaneous pacing electrodes is shown, antero-posterior (A.) and antero-lateral (B.). There is no significant difference in pacing thresholds between the two conformations.

Related posts:

Manual resuscitators Error, Man and Machine Electrical hazards and their prevention Atmospheric pollution Automatic ventilators Infusion equipment and intravenous anaesthesia

Stay updated, free articles. Join our Telegram channel
Tags:
Jun 1, 2016 | Posted by in ANESTHESIA | Comments Off on Pacemakers and defibrillators

Full access? Get Clinical Tree
Get Clinical Tree app for offline access